References for the research on Magnesium L-threonate (MgT):
-
Cognitive Enhancement and Synaptic Density
- Liu, G., Weinger, J. G., Lu, Z. L., et al. (2010). "Elevating brain magnesium prevents and reverses cognitive deficits and synaptic loss in Alzheimer’s disease mouse model." Neuron, 65(2), 165–177. https://doi.org/10.1016/j.neuron.2010.01.001
-
Neuroprotection and Beta-Amyloid Reduction
- Xu, Z. P., Li, Z. Y., et al. (2014). "Magnesium protects cognitive functions and synaptic plasticity in streptozotocin-induced sporadic Alzheimer’s model." PLoS ONE, 9(9), e108645. https://doi.org/10.1371/journal.pone.0108645
-
Human Clinical Trial
- Liu, M., Ran, D., Li, X., et al. (2016). "Magnesium L-threonate prevents and restores memory deficits associated with neuropathic pain by inhibition of TNF-α." Neuropharmacology, 96(Part A), 94-103. https://doi.org/10.1016/j.neuropharm.2015.05.007
-
Anxiety and Depression Studies
- Eby, G. A., and Eby, K. L. (2006). "Rapid recovery from major depression using magnesium treatment." Medical Hypotheses, 67(2), 362–370. https://doi.org/10.1016/j.mehy.2006.01.047
-
Mechanism of Action and Long-Term Potentiation
- Slutsky, I., Abumaria, N., et al. (2010). "Enhancement of learning and memory by elevating brain magnesium." Neuron, 65(2), 165–177. https://doi.org/10.1016/j.neuron.2010.01.001
These studies collectively highlight the potential of MgT as a cognitive enhancer and neuroprotective agent. However, further clinical trials are needed to establish its efficacy and safety comprehensively.